鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/11 | 2,445 | 2,499 | 2,400 | 2,469 | +50 | +2.1% | 47,100 |
2018/12/10 | 2,524 | 2,524 | 2,412 | 2,419 | -55 | -2.2% | 70,400 |
2018/12/07 | 2,507 | 2,536 | 2,340 | 2,474 | -111 | -4.3% | 176,900 |
2018/12/06 | 2,536 | 2,589 | 2,523 | 2,585 | +58 | +2.3% | 50,500 |
2018/12/05 | 2,524 | 2,567 | 2,517 | 2,527 | -12 | -0.5% | 43,300 |
2018/12/04 | 2,516 | 2,584 | 2,510 | 2,539 | -15 | -0.6% | 79,400 |
2018/12/03 | 2,480 | 2,591 | 2,480 | 2,554 | -76 | -2.9% | 251,600 |
2018/11/30 | 2,350 | 2,666 | 2,350 | 2,630 | +326 | +14.1% | 520,300 |
2018/11/29 | 2,330 | 2,349 | 2,301 | 2,304 | -26 | -1.1% | 23,200 |
2018/11/28 | 2,314 | 2,349 | 2,310 | 2,330 | +16 | +0.7% | 20,100 |
2018/11/27 | 2,299 | 2,319 | 2,283 | 2,314 | +15 | +0.7% | 26,600 |
2018/11/26 | 2,275 | 2,321 | 2,275 | 2,299 | +9 | +0.4% | 27,000 |
2018/11/22 | 2,228 | 2,306 | 2,228 | 2,290 | -6 | -0.3% | 83,100 |
2018/11/21 | 2,327 | 2,327 | 2,295 | 2,296 | -36 | -1.5% | 43,800 |
2018/11/20 | 2,372 | 2,372 | 2,323 | 2,332 | -48 | -2% | 23,800 |
2018/11/19 | 2,397 | 2,398 | 2,370 | 2,380 | -33 | -1.4% | 34,100 |
2018/11/16 | 2,393 | 2,429 | 2,386 | 2,413 | +20 | +0.8% | 20,700 |
2018/11/15 | 2,381 | 2,406 | 2,379 | 2,393 | -12 | -0.5% | 19,300 |
2018/11/14 | 2,402 | 2,409 | 2,363 | 2,405 | +23 | +1% | 44,000 |
2018/11/13 | 2,377 | 2,402 | 2,366 | 2,382 | -9 | -0.4% | 38,100 |
2018/11/12 | 2,390 | 2,408 | 2,373 | 2,391 | -17 | -0.7% | 17,300 |
2018/11/09 | 2,419 | 2,471 | 2,407 | 2,408 | -21 | -0.9% | 25,100 |
2018/11/08 | 2,410 | 2,456 | 2,410 | 2,429 | +53 | +2.2% | 29,300 |
2018/11/07 | 2,378 | 2,408 | 2,362 | 2,376 | -6 | -0.3% | 27,600 |
2018/11/06 | 2,377 | 2,420 | 2,371 | 2,382 | +51 | +2.2% | 36,200 |
2018/11/05 | 2,331 | 2,372 | 2,296 | 2,331 | +45 | +2% | 64,300 |
2018/11/02 | 2,311 | 2,320 | 2,260 | 2,286 | -14 | -0.6% | 119,700 |
2018/11/01 | 2,637 | 2,637 | 2,300 | 2,300 | -187 | -7.5% | 128,400 |
2018/10/31 | 2,453 | 2,526 | 2,453 | 2,487 | +42 | +1.7% | 38,400 |
2018/10/30 | 2,431 | 2,482 | 2,421 | 2,445 | -11 | -0.4% | 45,100 |
2018/10/29 | 2,435 | 2,517 | 2,401 | 2,456 | +8 | +0.3% | 47,000 |
2018/10/26 | 2,442 | 2,467 | 2,400 | 2,448 | +10 | +0.4% | 61,100 |
2018/10/25 | 2,505 | 2,514 | 2,430 | 2,438 | -117 | -4.6% | 43,600 |
2018/10/24 | 2,532 | 2,562 | 2,526 | 2,555 | +24 | +0.9% | 21,400 |
2018/10/23 | 2,560 | 2,574 | 2,531 | 2,531 | -37 | -1.4% | 40,000 |
2018/10/22 | 2,567 | 2,582 | 2,542 | 2,568 | -25 | -1% | 17,000 |
2018/10/19 | 2,561 | 2,594 | 2,558 | 2,593 | ±0 | ±0% | 15,600 |
2018/10/18 | 2,579 | 2,619 | 2,578 | 2,593 | +7 | +0.3% | 32,700 |
2018/10/17 | 2,544 | 2,590 | 2,521 | 2,586 | +44 | +1.7% | 45,900 |
2018/10/16 | 2,533 | 2,555 | 2,521 | 2,542 | -12 | -0.5% | 31,200 |
2018/10/15 | 2,566 | 2,597 | 2,545 | 2,554 | -10 | -0.4% | 36,300 |
2018/10/12 | 2,565 | 2,606 | 2,544 | 2,564 | -1 | ±0% | 52,000 |
2018/10/11 | 2,555 | 2,575 | 2,510 | 2,565 | -70 | -2.7% | 74,600 |
2018/10/10 | 2,712 | 2,712 | 2,625 | 2,635 | -94 | -3.4% | 81,700 |
2018/10/09 | 2,776 | 2,776 | 2,700 | 2,729 | -59 | -2.1% | 46,000 |
2018/10/05 | 2,748 | 2,810 | 2,728 | 2,788 | +39 | +1.4% | 41,700 |
2018/10/04 | 2,740 | 2,758 | 2,709 | 2,749 | +27 | +1% | 49,900 |
2018/10/03 | 2,652 | 2,734 | 2,652 | 2,722 | +70 | +2.6% | 43,700 |
2018/10/02 | 2,667 | 2,695 | 2,643 | 2,652 | -65 | -2.4% | 65,100 |
2018/10/01 | 2,725 | 2,767 | 2,703 | 2,717 | -18 | -0.7% | 45,700 |
1451~
1500
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム